Mats Wahlstrom, Director, 10% Owner at TriSalus Life Sciences, Inc. (TLSI), bought 5,000 shares at $4.55 ($23K) on 2024-11-22, disclosed to the SEC on 2024-11-25.
Open-market purchase of $23k TLSI by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| TLSI | BUY | 2024-11-22 | $47K | — | Filing → |
| CHRS | SELL | 2020-06-19 | $6.9M | — | Filing → |
| CHRS | SELL | 2020-03-05 | $4.8M | — | Filing → |